New projects funded by Winship Invest$ to advance innovative cancer research
Pictured clockwise from top left: Candace Fleischer, PhD, Homa Ghalei, PhD, Kimberly Hoang, MD, Kevin Kalinsky, MD, MS, Yong Teng, PhD, and Yong Wan, PhD
Six investigators will receive $300,000 in funding for new cancer research projects through Winship Invest$, a peer-reviewed program designed to fund novel, innovative cancer research at Winship Cancer Institute of Emory University.
Winship Invest$ is supported by philanthropic contributions and developmental funds from Winship's Cancer Center Support Grant (P30CA138292) awarded by the National Cancer Institute. Ithas two funding cycles every year and solicits proposals in strategic research domains. The most recent call for proposals focused on projects related to precision immunotherapy, early detection, risk reduction and prevention, team science, neuro-oncology, breast cancer and general cancer research.
This cycle's Winship Invest$ pilot grant projects are below.
Development of Ultrahigh Field Magnetic Resonance Methods to Image Glutamine for Applications in Gliomas Candace Fleischer, PhD Assistant professor, Department of Radiology and Imaging Sciences Emory University School of Medicine
Towards Targeting snoRNAs in Lung Cancer Homa Ghalei, PhD Assistant professor, Department of Biochemistry Emory University School of Medicine
Characterizing Complement Inhibition in Radiation Necrosis Kimberly Hoang, MD Assistant professor, Department of Neurosurgery Emory University School of Medicine
Early Identification of Tumor Response in Patients with Breast Cancer Undergoing Immunotherapy and Chemotherapy Kevin Kalinsky, MD, MS Associate professor, Department of Hematology and Medical Oncology Emory University School of Medicine Director, Glenn Family Breast Center Winship Cancer Institute of Emory University
Implication of GSTM1 Expression in Racial Survival Disparities in Head and Neck Cancer Yong Teng, PhD Associate professor, Department of Hematology and Medical Oncology Emory University School of Medicine
Targeting Homologous Recombination Deficiency in Breast Cancer Treatment Yong Wan, PhD SOM Endowed Professor, Department of Pharmacology and Chemical Biology Professor, Department of Hematology and Oncology Emory University School of Medicine Director for basic research, Glenn Family Breast Center Winship Cancer Institute of Emory University